Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dooley

Showing results (101-110 of 263) with videos related to

Pageof 27
Sort By:
Journal of the International Society of Sports Nutrition|February 14, 2019
Chocolate Milk versus carbohydrate supplements in adolescent athletes: a field based studyKatelyn A Born, Erin E Dooley, P Andy Cheshire, et al.
BMJ Open|November 10, 2022
INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trialAnushka Naidoo, Kelly E Dooley, Kogieleum Naidoo, et al.
JAMA Network Open|March 18, 2022
Association of Hearing Impairment and 24-Hour Total Movement Activity in a Representative Sample of US AdultsPablo Martinez-Amezcua, Erin E Dooley, Nicholas S Reed, et al.
Trials|February 15, 2020
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)Ruth Nabisere, Joseph Musaazi, Paolo Denti, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosisAmit Kaushik, Nicole C Ammerman, Rokeya Tasneen, et al.
Frontiers in Pharmacology|May 14, 2023
A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitisRoeland E Wasmann, Tiziana Masini, Kerri Viney, et al.
Clinical and Translational Science|June 1, 2017
New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment ResponseI H Bartelink, N Zhang, R J Keizer, et al.
American Journal of Respiratory and Critical Care Medicine|May 16, 2020
Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis InfectionJennifer E Hibma, Kendra K Radtke, Susan E Dorman, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 24, 2022
Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milkBuyisile Mkhize, Tracy Kellermann, Jennifer Norman, et al.
Preventive Medicine Reports|June 17, 2022
Daily and hourly patterns of physical activity and sedentary behavior of older adults: Atherosclerosis risk in communities (ARIC) studyErin E Dooley, Lisa A Pompeii, Priya Palta, et al.
Pageof 27

Showing results (101-110 of 263) with videos related to

Sort By:
Pageof 27
Journal of the International Society of Sports Nutrition|February 14, 2019
Chocolate Milk versus carbohydrate supplements in adolescent athletes: a field based studyKatelyn A Born, Erin E Dooley, P Andy Cheshire, et al.
BMJ Open|November 10, 2022
INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trialAnushka Naidoo, Kelly E Dooley, Kogieleum Naidoo, et al.
JAMA Network Open|March 18, 2022
Association of Hearing Impairment and 24-Hour Total Movement Activity in a Representative Sample of US AdultsPablo Martinez-Amezcua, Erin E Dooley, Nicholas S Reed, et al.
Trials|February 15, 2020
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)Ruth Nabisere, Joseph Musaazi, Paolo Denti, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosisAmit Kaushik, Nicole C Ammerman, Rokeya Tasneen, et al.
Frontiers in Pharmacology|May 14, 2023
A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitisRoeland E Wasmann, Tiziana Masini, Kerri Viney, et al.
Clinical and Translational Science|June 1, 2017
New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment ResponseI H Bartelink, N Zhang, R J Keizer, et al.
American Journal of Respiratory and Critical Care Medicine|May 16, 2020
Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis InfectionJennifer E Hibma, Kendra K Radtke, Susan E Dorman, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 24, 2022
Validation and application of a quantitative liquid chromatography tandem mass spectrometry assay for the analysis of rifapentine and 25-O-desacetyl rifapentine in human milkBuyisile Mkhize, Tracy Kellermann, Jennifer Norman, et al.
Preventive Medicine Reports|June 17, 2022
Daily and hourly patterns of physical activity and sedentary behavior of older adults: Atherosclerosis risk in communities (ARIC) studyErin E Dooley, Lisa A Pompeii, Priya Palta, et al.
Pageof 27